HIV Molecular Immunology Database
Databases
Sequence DB
Immunology DB
Neutralization DB
Ab contacts DB
HCV Databases
HFV Databases
Search
CTL/CD8+ Search
T Helper/CD4+ Search
Antibody Search
CTL Variant Search
T Helper Variant Search
Patient Search
JSON API Information
Search Help
Old Search
Tools
All Immunology Tools
CATNAP
CombiNAber
HIV Genome Browser
Quickalign
CAByN
Analyze Align
Alignment Slicer
PeptGen
PepMap
Motif Scan
Hepitope
HLA Freq Analysis
ELF
Sequence Locator
SeqPublish
Heatmap
Epigraph Vaccine Suite
Mosaic Vaccine Suite
N-Glycosite
Highlighter
Protein Feature Accent
Variable Region
Neutralization Index
Products
Epitope Maps
Epitope & Antibody Tables
Epitope Alignments
Epitope Density Plots
T-Cell Epitope Variants
Neutralizing Ab Resources
& CATNAP
Data Sets: HLA Typing and
Epitope Mapping
Tools & Links
Info
Compendia
Reviews
About the Database
FAQ
How to Cite this Database
Sequence Alignments
Database Tutorials
HIV Molecular Immunology Database Search
T-Helper/CD4+ Search
Search Help
How to Find Information
HIV protein
-ALL-
Gag
p17
p24
p2p7p1p6
Pol
Gag/Pol-TF
Protease
RT
Integrase
Vif
Vpr
Tat
Rev
Vpu
Env
Nef
HIV-1
HXB2 protein location
–
Results overlap with query location
Results contained within query location
Results exactly match query location
HXB2 DNA location
–
Results overlap with query location
Epitope
Results contain query sequence
Results exactly match query sequence
Results fuzzy match to query sequence
Epitope name
Record number
Subtype
-ALL-
A
A1
AG
B
BF
C
CRF01_AE
CRF02_AG
D
F
F1
F2
G
H
M group
multiple
Immunogen
-ALL-
engineered
HIV-1 and GBV-C co-infection
HIV-1 and HCV co-infection
HIV-1 exposed seronegative
HIV-1 infection
HIV-1 or HIV-2 infection
in vitro stimulation or selection
peptide-HLA interaction
SHIV infection
vaccine
virus
Vaccine details
if Immunogen is Vaccine
Vaccine type
-ALL-
adenovirus
adenovirus type 5 (Ad5)
AIDSVAX B/E
ALVAC-HIV
attenuated poxvirus vector NYVAC
bacteriophage coat protein
baculovirus
canarypox
canarypox prime with gp120 boost
canarypox prime with gp160 boost
canarypox prime with recombinant protein boost
coxsackievirus
dihydrolipoyl acetyltransferase E2 protein, of Bacillus stearothermophilus
DNA
DNA prime with Ad5 boost
DNA prime with gp160 boost
DNA prime with modified vaccinia Ankara (MVA) boost
DNA prime with peptide boost
DNA prime with poxvirus boost
DNA prime with protein boost
DNA prime with vaccinia boost
DNA prime with virus-like particle (VLP) boost
DNA with CMV promotor
DNA with protein boost
fowlpoxvirus
gp120 depleted virus HZ321 (REMUNE(TM))
gp120 depleted whole killed virus
gp160 prime with gp120 boost
heat-shock protein (HSP70)
HIV-1 immunogen
HIV-1 peptide in filamentous bacteriophage major coat protein
HIVconsv
HIV infected-cell lysate
E. coli recombinant protein
inactivated HIV
ISCOM
lipopeptide
Listeria monocytogenes
modified vaccinia Ankara (MVA)
nanoparticle
non-replicating adenovirus
peptide
peptide in cowpea mosaic virus (CPMV)
peptide presented on icosahedral protein scaffold
peptide prime with protein boost
polyepitope
poxvirus
protein
protein-Ab complex
Salmonella
Streptococcus gordonii
vaccinia
vaccinia prime with gp120 boost
virus-like particle (VLP)
Vaccine strain
-ALL-
A clade
A clade 92RW020
A clade BG505
A clade consensus
A clade UG5.94UG018
AG recombinant HZ321
B clade
B clade 1007
B clade 1035
B clade 89.6
B clade BH10
B clade BH8
B clade BRU
B clade HXB2
B clade HXB3
B clade HXBc2
B clade IIIB
B clade JRFL
B clade LAI
B clade MN
B clade MN/LAI-2
B clade NL43
B clade pNL423-ZF1
B clade SF162
B clade SF2
B clade W61D
C clade
C clade 96ZM651
C clade 97CN54
C clade 97ZA012
C clade consensus
C clade Du151
C clade Du422
CRF01_AE clade
D clade
D clade UG92005
M group consensus
modified B clade IIIB
multiple epitope immunogen
other
SIV
Vaccine component
-ALL-
complete genome
Env
EnvΔV2
Env trimers
Env V3
Gag
Gag-Pol
gp120
gp120 depleted virus
gp140
gp140ΔV2
gp160
gp160 deletions
gp41
HIV-1
Nef
Nef-Tat fusion
other
p17 Gag
p17/p24 Gag
p24 Gag
p25 Gag
Pol
Protease
Rev
RT
Tat
Vif
virus
Vpr
Vpu
Adjuvant
-ALL-
aluminum hydroxide (alum)
aluminum phosphate
AS01
AS01B
AS02A
AS02V
B7
Br-cAMP
Bupivacaine
CAF01
CD40
CD80
CD86
Cholera toxin (CT)
Complete Freund's Adjuvant (CFA)
CpG immunostimulatory sequence (ISS)
E. coli mutant heat labile enterotoxin (LT-R72)
E.coli mutant heat-labile toxin (mLT-R192G)
G-CSF
GM-CSF
GM-CSF/ENV chimera
Growth Hormone
IFNγ
IL-12
IL-15
IL-18
IL-1α
IL-2
IL-2/Ig
IL-4
IL-7
IL-8
Immune stimulating complexes (ISCOM)
Incomplete Freund's Adjuvant (IFA)
Keyhole Limpit Haemocyanin (KLH)
lipid A
liposome
macrophage activating lipopeptide-2 (MALP-2)
MCP1
M-CSF
MF59
MIP-1α
Montanide (ISA 51)
MPL-SE adjuvant
muramyl-dipeptide base adjuvant (Syntex)
Other
P3CSS
PLG
QS21
Quillaja saponin (Quil-A)
RANTES
Ribi adjuvant (MPL+TDM) (RIBI)
SDF-1α
Thymosin α-1
Tumor Necrosis Factor α (TNFα)
Tumor Necrosis Factor β (TNFβ)
ubiquitin
Species
-ALL-
baboon
chimpanzee
goat
guinea pig
human
humanized mouse
macaque
mouse
rabbit
rat
transgenic mouse
Restricting MHC/HLA
-ALL-
DP4
DP5
DQ
DQ2
DQ3
DQ5
DQ6
DQ7
DQ8
DQA1*01
DQB1*05
DQB1*06
DQw7
DR
DR0101
DR1
DR11
DR13
DR13.02
DR2
DR2 or DR3
DR3
DR4
DR5
DR51
DR5(11.01)
DR6
DR7
DRB
DRB1*01
DRB1*01:01
DRB1*03
DRB1*03:01
DRB1*03:02
DRB1*04
DRB1*04:01
DRB1*04:02
DRB1*04:03
DRB1*04:04
DRB1*04:05
DRB1*07:01
DRB1*08:01
DRB1*08:04
DRB1*09:01
DRB1*10:01
DRB1*11:01
DRB1*12:01
DRB1*12:02
DRB1*13
DRB1*13:01
DRB1*13:02
DRB1*13:03
DRB1*13:04
DRB1*14:01
DRB1*15:01
DRB1*15:02
DRB3*01:01
DRB3*02:02
DRB3*03:01
DRB3*03:03
DRB4*01:01
DRB5
DRB5*01:01
DRS
DR supermotif
DRw6
H-2 Ad
H-2Dd
H-2Eα Eβ k
H-2Ek
H-2 IAb
H-2 I-Ad
H-2b
H-2bxk
H-2d
H-2f
H-2i5
H-2k
H-2s
H-2sxd
H-2t4
I-Ab
I-Ad
I-Ak
Mamu-DRB1*0406
Mamu-DRB*W201
Experimental methods
and outcome measured
-ALL-
CD4 T-cell Elispot - IFNγ
CD8 T-cell Elispot - IFNγ
Chromium-release assay
CTL suppression of replication
Cytokine production
Degranulation, CD107a and b cell surface mobilization
Delayed-type hypersensitivity (DTH)
Flow cytometric T-cell cytokine assay
FluoroSpot
Gene expression assay/analyses
HLA binding
Intracellular cytokine staining
Other
Peptide titration
Proliferation
Relative replication capacity assay
T-cell Elispot
Tetramer binding
Th support of CTL response
Author
First
Last
Country
-ALL-
Australia
Brazil
Canada
China
Cote D'Ivoire
Denmark
France
Gambia
Germany
Guinea-Bissau
India
Italy
Jamaica
Japan
Kenya
Malawi
Netherlands
Russia
Senegal
South Africa
Spain
Sweden
Switzerland
Thailand
United Kingdom
United States
Keywords
-ALL-
acute/early infection
adjuvant comparison
antagonism
antibody interactions
assay or method development
binding affinity
CD4+ CTL
characterizing CD8+ T cells
chronic infection
computational prediction
co-receptor
dendritic cells
drug resistance
dynamics
early-expressed proteins
early treatment
elite controllers and/or long-term non-progressors
epitope processing
escape
genital and mucosal immunity
glycosylation
HAART, ART
HIV-2
HIV exposed persistently seronegative (HEPS)
HLA associated polymorphism
HLA cross-presentation
immunodominance
immunomodulation
immunotherapy
isotype switch
junction or fusion peptide
kinetics
memory cells
mother-to-infant transmission
NK cells
novel epitope
optimal epitope
polyclonal antibodies
protective allele
rate of progression
regulatory T cells
responses in children
review
structure
subtype comparisons
superinfection
supertype
supervised treatment interruptions (STI)
synthetic peptide
TCR usage
Th1
Th2
therapeutic vaccine
vaccine antigen design
vaccine-induced immune responses
variant cross-reactivity
viral fitness and/or reversion
Notes
Questions or comments? Contact us at
immuno@lanl.gov